Clinical Trial Update: Testing of DNA Extracted From Tumor Tissue Biopsy Samples Using Therascreen KRAS RGQ PCR Kit

View source ↗

Summary

Completed clinical trial evaluating the Therascreen KRAS RGQ PCR Kit for analyzing DNA from tumor tissue biopsies in non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Therascreen KRAS RGQ PCR Kit (KRAS RGQ PCR Kit)

Snippet

Sponsor: QIAGEN Gaithersburg, Inc | Conditions: Non Small Cell Lung Cancer | Status: COMPLETED